Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry

被引:12
作者
Chandrasekhar, Jaya [1 ]
Baber, Usman [1 ]
Sartori, Samantha [1 ]
Aquino, Melissa [1 ]
Tomey, Matthew [1 ]
Kruckoff, Mitchell [2 ]
Moliterno, David [3 ]
Henry, Timothy D. [4 ]
Weisz, Giora [5 ]
Gibson, C. Michael [6 ]
Iakovou, Ioannis [7 ]
Kini, Annapoorna [1 ]
Faggioni, Michela [1 ]
Vogel, Birgit [1 ]
Farhan, Serdar [1 ]
Colombo, Antonio [8 ]
Steg, P. Gabriel [9 ]
Witzenbichler, Bernhard [10 ]
Chieffo, Alaide [8 ]
Cohen, David [11 ]
Stuckey, Thomas [12 ]
Ariti, Cono [13 ]
Pocock, Stuart [13 ]
Dangas, George [1 ]
Mehran, Roxana [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ Kentucky, Lexington, KY USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Shaare Zedek Med Ctr, Jerusalem, Israel
[6] Harvard Med Sch, Cambridge, MA USA
[7] Onassis Cardiac Surg Ctr, Athens, Greece
[8] Osped San Raffaele, Milan, Italy
[9] Hop Bichat Claude Bernard, Paris, France
[10] Helios Amper Klinikum, Dachau, Germany
[11] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA
[12] LeBauer Cardiovasc Res Fdn, Moses Cone Heart & Vasc Ctr, Greensboro, NC USA
[13] London Sch Hyg & Trop Med, London, England
关键词
Left main or proximal LAD; Percutaneous coronary intervention; Dual antiplatelet therapy cessation; Drug eluting stents; Major adverse cardiac events; PERCUTANEOUS CORONARY INTERVENTION; EVEROLIMUS-ELUTING STENTS; BYPASS-SURGERY; THROMBOSIS; RISK; IMPLANTATION; DISEASE; TAXUS; BIFURCATIONS; PROPENSITY;
D O I
10.1016/j.ijcard.2017.05.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Percutaneous coronary intervention (PCI) of the left main (LM) or proximal left anterior descending artery (pLAD) is considered high-risk as these segments subtend substantial left ventricular myocardial area. We assessed the patterns and associations between dual antiplatelet therapy (DAPT) cessation and 2-year outcomes in LM/pLAD vs. other PCI from the all-comer PARIS registry. Methods: Two-year major adverse cardiovascular events (MACE) were a composite of cardiac death, myocardial infarction, definite/probable stent thrombosis or target lesion revascularization. DAPT cessation was predefined as physician-guided permanent discontinuation, temporary interruption, or non-recommended disruption due to non-compliance or bleeding. Results: Of the study population (n = 5018), 25.0% (n= 1252) underwent LM/pLAD PCI and 75.0% (n= 3766) PCI to other segments. Compared to others, LM/pLAD patients presented with fewer comorbidities, less frequent acute coronary syndromes but more multivessel and bifurcation disease treated with greater stent lengths. Two-year adjusted risk of MACE (11.4% vs. 11.6%; HR 1.10, 95% CI 0.90-1.34, p = 0.36) was similar between LM/pLAD vs. other patients. DAPT discontinuation was significantly higher (43.3% vs. 39.4%, p = 0.01) in LM/pLAD patients with borderline significance for lower disruption (10.0% vs. 14.7%, p = 0.059) compared to other patients. DAPT discontinuation was not associated with higher risk of MACE in LM/pLAD (HR 0.65, 95% CI 0.34-1.25) or other PCI groups (HR 0.67, 95% CI 0.47-0.95). Conclusions: LM/pLAD PCI was not an independent predictor of 2-year MACE. Compared to other PCI, patients undergoing LM/pLAD PCI had higher rates of physician recommended DAPT discontinuation, however, discontinuation did not result in greater adverse events. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 31 条
[1]   Predictors and Outcomes of Recurrent Stent Thrombosis Results From a Multicenter Registry [J].
Armstrong, Ehrin J. ;
Sab, Shiv ;
Singh, Gagan D. ;
Lim, Wayland ;
Yeo, Khung-Keong ;
Waldo, Stephen W. ;
Patel, Mitul ;
Reeves, Ryan ;
MacGregor, John S. ;
Low, Reginald I. ;
Shunk, Kendrick A. ;
Mahmud, Ehtisham ;
Rogers, Jason H. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (10) :1105-1113
[2]   Angiographic Stent Thrombosis at Coronary Bifurcations Short- and Long-Term Prognosis [J].
Armstrong, Ehrin J. ;
Yeo, Khung Keong ;
Javed, Usman ;
Mahmud, Ehtisham ;
Patel, Mitul ;
Shunk, Kendrick A. ;
MacGregor, John S. ;
Low, Reginald I. ;
Rogers, Jason H. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (01) :57-63
[3]   Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents Risk Scores From PARIS [J].
Baber, Usman ;
Mehran, Roxana ;
Giustino, Gennaro ;
Cohen, David J. ;
Henry, Timothy D. ;
Sartori, Samantha ;
Ariti, Cono ;
Litherland, Claire ;
Dangas, George ;
Gibson, C. Michael ;
Krucoff, Mitchell W. ;
Moliterno, David J. ;
Kirtane, Ajay J. ;
Stone, Gregg W. ;
Colombo, Antonio ;
Chieffo, Alaide ;
Kini, Annapoorna S. ;
Witzenbichler, Bernhard ;
Weisz, Giora ;
Steg, Philippe Gabriel ;
Pocock, Stuart .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (19) :2224-2234
[4]   Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry [J].
Buchanan, Gill Louise ;
Chieffo, Alaide ;
Bernelli, Chiara ;
Montorfano, Matteo ;
Carlino, Mauro ;
Latib, Azeem ;
Figini, Filippo ;
Giannini, Francesco ;
Durante, Alessandro ;
Ielasi, Alfonso ;
Castelli, Alfredo ;
Colombo, Antonio .
EUROINTERVENTION, 2013, 9 (07) :809-816
[5]   Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management [J].
Califf, RM ;
Armstrong, PW ;
Carver, JR ;
DAgostino, RB ;
Strauss, WE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :1007-1019
[6]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[7]   Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes [J].
Dangas, George D. ;
Claessen, Bimmer E. ;
Mehran, Roxana ;
Xu, Ke ;
Fahy, Martin ;
Parise, Helen ;
Henriques, Jose P. S. ;
Ohman, E. Magnus ;
White, Harvey D. ;
Stone, Gregg W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (11) :1097-1105
[8]   Current management of left main coronary artery disease [J].
Fajadet, Jean ;
Chieffo, Alaide .
EUROPEAN HEART JOURNAL, 2012, 33 (01) :36-U169
[9]   Strategies for Multivessel Revascularization in Patients with Diabetes [J].
Farkouh, Michael E. ;
Domanski, Michael ;
Sleeper, Lynn A. ;
Siami, Flora S. ;
Dangas, George ;
Mack, Michael ;
Yang, May ;
Cohen, David J. ;
Rosenberg, Yves ;
Solomon, Scott D. ;
Desai, Akshay S. ;
Gersh, Bernard J. ;
Magnuson, Elizabeth A. ;
Lansky, Alexandra ;
Boineau, Robin ;
Weinberger, Jesse ;
Ramanathan, Krishnan ;
Sousa, J. Eduardo ;
Rankin, Jamie ;
Bhargava, Balram ;
Buse, John ;
Hueb, Whady ;
Smith, Craig R. ;
Muratov, Victoria ;
Bansilal, Sameer ;
King, Spencer, III ;
Bertrand, Michel ;
Fuster, Valentin .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2375-2384
[10]   Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents - A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians [J].
Grines, Cindy L. ;
Bonow, Robert O. ;
Casey, Donald E., Jr. ;
Gardner, Timothy J. ;
Lockhart, Peter B. ;
Moliterno, David J. ;
O'Gara, Patrick ;
Whitlow, Patrick .
CIRCULATION, 2007, 115 (06) :813-818